1

5 Simple Statements About ABBV-744 clinical trial phase 1 results Explained

News Discuss 
In Section A, members will receive diverse doses and schedules of oral ABBV-744 pill to discover safe dosing routine. More contributors will likely be enrolled within the identified monotherapy dosign regimen. In Section B, members will receive oral ruxolitinib and ABBV-744 is going to be specified as "include-on" therapy. In https://elizabethg444seu8.yourkwikimage.com/user

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story